Thermo Fisher Scientific (XSGO:TMOCL) Cyclically Adjusted Revenue per Share: CLP93,401.82 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSGO:TMOCL Thermo Fisher Scientific Inc XSGO:TMOCL
65 GF Score
Price CLP448,200.00
GF Value CLP528,590.22
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Cyclically Adjusted Revenue per Share?

Thermo Fisher Scientific XSGO:TMOCL 65 Cyclically Adjusted Revenue per Share is CLP93,401.82 as of Jun. 2026. GuruFocus rates XSGO:TMOCL with a GF Score™ of 65/100 and a GF Value™ of CLP528,590.22 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Thermo Fisher Scientific's adjusted revenue per share for the three months ended in Jun. 2026 was CLP29,271.781. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CLP93,401.82 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Thermo Fisher Scientific's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Thermo Fisher Scientific was 16.50% per year. The lowest was -1.30% per year. And the median was 9.50% per year.

As of today (2026-08-13), Thermo Fisher Scientific's current stock price is CLP448200.00. Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was CLP93,401.82. Thermo Fisher Scientific's Cyclically Adjusted PS Ratio of today is 4.80.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Thermo Fisher Scientific was 10.98. The lowest was 4.16. And the median was 6.43.


Thermo Fisher Scientific  (XSGO:TMOCL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Thermo Fisher Scientific's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=448200.00/93401.82
=4.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Thermo Fisher Scientific was 10.98. The lowest was 4.16. And the median was 6.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Related Terms


Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 89,168.19

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89,739.54 89,721.50 89,168.19 108,665.81 93,401.82

XSGO:TMOCL vs DHR, IDXX, A: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cyclically Adjusted PS Ratio falls into.


XSGO:TMOCL
65GF Score
Thermo Fisher Scientific Inc XSGO:TMOCL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thermo Fisher Scientific's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29271.781/333.9520*333.9520
=29,271.781

Current CPI (Jun. 2026) = 333.9520.

Thermo Fisher Scientific Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 7,547.429 241.428 10,439.879
201612 8,344.605 241.432 11,542.370
201703 8,005.785 243.801 10,966.107
201706 8,437.782 244.955 11,503.395
201709 8,006.724 246.819 10,833.289
201712 9,510.984 246.524 12,883.987
201803 8,708.974 249.554 11,654.308
201806 9,543.952 251.989 12,648.258
201809 9,917.847 252.439 13,120.337
201812 10,967.774 251.233 14,578.937
201903 10,176.828 254.202 13,369.572
201906 10,829.678 256.143 14,119.428
201909 11,158.433 256.759 14,513.147
201912 12,967.621 256.974 16,852.144
202003 13,088.151 258.115 16,933.592
202006 13,831.970 257.797 17,918.029
202009 16,513.587 260.280 21,187.742
202012 19,311.300 260.474 24,758.891
202103 18,117.826 264.877 22,842.618
202106 17,062.345 271.696 20,971.984
202109 18,457.164 274.310 22,470.223
202112 22,908.720 278.802 27,440.308
202203 23,887.632 287.504 27,746.823
202206 24,149.022 296.311 27,216.722
202209 24,993.474 296.808 28,121.279
202212 25,483.274 296.797 28,673.438
202303 22,286.701 301.836 24,658.054
202306 22,021.560 305.109 24,103.334
202309 24,162.265 307.789 26,216.131
202312 24,570.821 306.746 26,750.063
202403 26,123.517 312.332 27,931.819
202406 25,537.678 314.175 27,145.249
202409 25,553.311 315.301 27,064.866
202412 29,293.431 315.605 30,996.340
202503 25,495.102 319.799 26,623.411
202506 26,916.634 322.561 27,867.175
202509 28,238.037 324.800 29,033.710
202512 29,533.962 324.054 30,436.056
202603 26,929.642 330.213 27,234.566
202606 29,271.781 333.952 29,271.781

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CLP93,401.82 mean?
Thermo Fisher Scientific (XSGO:TMOCL) has a Cyclically Adjusted Revenue per Share of CLP93,401.82 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors.
Is Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share too high?
Thermo Fisher Scientific's current Cyclically Adjusted Revenue per Share is CLP93,401.82. Overall, Thermo Fisher Scientific has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share compare to DHR and IDXX?
Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share of CLP93,401.82 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current Cyclically Adjusted Revenue per Share is CLP93,401.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (XSGO:TMOCL) is currently considered Modestly Undervalued. The stock's GF Value™ is CLP528,590.22, compared to a current price of CLP448,200.00 — trading 15.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is CLP93,401.82. Thermo Fisher Scientific's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Thermo Fisher Scientific (XSGO:TMOCL), the current Cyclically Adjusted Revenue per Share is CLP93,401.82 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (XSGO:TMOCL) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of CLP448,200.00 is trading 15.2% below its estimated GF Value™ of CLP528,590.22. GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.

Key valuation signals for XSGO:TMOCL:

  • Cyclically Adjusted Revenue per Share: CLP93,401.82
  • GF Value™: CLP528,590.22 vs. price of CLP448,200.00 (15.2% below fair value)
  • GF Score™: 65/100 with 10 warning signs

No single metric tells the full story. See the XSGO:TMOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
65GF Score

Get the complete analysis for XSGO:TMOCL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CLP448,200.00
Price
CLP528,590.22
GF Value